Veterinary Product Information
Fel-O-Vax Lv-K IV + CaliciVax (Canada)
This page contains information on Fel-O-Vax Lv-K IV + CaliciVax for veterinary use.The information provided typically includes the following:
- Fel-O-Vax Lv-K IV + CaliciVax Indications
- Warnings and cautions for Fel-O-Vax Lv-K IV + CaliciVax
- Direction and dosage information for Fel-O-Vax Lv-K IV + CaliciVax
Fel-o-vax Lv-k Iv + Calicivax
This treatment applies to the following species:Feline Leukemia-rhinotracheitis-calici-panleukopenia-chlamydia Psittaci Vaccine
Killed Virus and Chlamydia
Includes Hemorrhagic Calici Strain
For subcutaneous vaccination of healthy cats 8 to 10 weeks of age or older, as an aid in the prevention of disease caused by feline leukemia, rhinotracheitis, calici, panleukopenia viruses and feline Chlamydia psittaci. The vaccine contains one additional feline calicivirus strain isolated from one hemorrhagic calicivirus outbreak that occurred in 1998 and was shown to protect vaccinated cats against calicivirus-induced hemorrhagic disease in controlled vaccination challenge experiments.
Dose
Inject one 1 mL dose subcutaneously using aseptic technique. Repeat in 3 to 4 weeks. Annual revaccination with a single dose of vaccine is recommended.Infovax-id® System
The INFOVAX-ID® System provides a simple and effective method of recording pertinent information on the vaccines administered to animals in a veterinary practice.
For vaccines requiring reconstitution, remove label from both vials and affix both labels to the animal's medical chart.
Using The Infovax-id® System
Can. Patent No. 2,237,570 C
1. |
Grasp the lower right hand corner of the tab at the arrow marked “Peel Here” between your thumb and forefinger (figure 1). |
![]() |
2. |
Pull steadily at a slight upward angle until the top portion of the label is separated from the vial (figure 2). |
![]() |
3. |
Place the label on the animal's medical chart. Press down on the label to ensure adhesion. |
|
Fel-O-Vax Lv-K IV + CaliciVax Caution
Store in the dark at 2° to 7°C (35° to 45°F). AVOID FREEZING. SHAKE WELL. In case of anaphylactoid reaction, administer epinephrine.Thimerosal, neomycin, polymyxin B and amphotericin B added as preservatives.
For Veterinary Use Only
U.S. Patent Nos. 5,047,238 - 5,242,686 - 6,004,563 - 6,042,835 and patents pending
© 2007 Fort Dodge Animal Health. All Rights Reserved.
Manufactured by Fort Dodge Animal Health, Fort Dodge, Iowa 50501 U.S.A.
U.S. Vet. License No. 112
Trademarks used under license
Distributed in Canada by Wyeth Animal Health, Division of Wyeth Canada, Guelph, Ontario, Canada
|
50 DOSES |
50 - 1 mL Vials of Vaccine |
C18296C |
Nac No.
11573540Division of Wyeth Canada
400 MICHENER ROAD, GUELPH, ON, N1K 1E4
| Telephone: | 519-837-2040 | |
| Order Desk: | 800-265-7200 | |
| Fax: | 519-837-9342 | |
| Website: | www.wyethah.ca |
![]() |
Every effort has been made to ensure the accuracy of the Fel-O-Vax Lv-K IV + CaliciVax information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Fel-O-Vax Lv-K IV + CaliciVax product label or package insert. |
![]() |
Printable Version | ![]() |
Email Page |










